NGM Bio Presents Preliminary Data from Phase 1 Monotherapy
NGM707 was generally well tolerated to the highest dose evaluated (1800 mg) in the monotherapy escalation; maximum tolerated dose was not reachedLinear...
Biopharmaceuticals Inc Esmoio Annual Congress European Society For Medical Oncology Immuno Oncology Esmoio Annual Congress European Society Medical Oncology Immuno
Source: globenewswire.com